Featured Topics
Calendar

November 12, 2024

Q3 2024 Results / Quarterly Statement

March 05, 2025

FY/Q4 2024 Results / Annual Report
Sustainability Report 2024
Press Releases
Share Price / Index
September 27, 2024
Not intended for UK Media
BlueRock Therapeutics’ investigational cell therapy bemdaneprocel for Parkinson’s disease shows positive data at 24-months
September 26, 2024
Not intended for U.S. and UK Media
Bayer submits application to U.S. FDA for third indication of darolutamide
September 10, 2024
Not intended for UK Media – Late-breaking data from Phase III long-term study OASIS 3 presented at 2024 TMS Annual Meeting:
Data from Phase III study OASIS 3 support efficacy and long-term safety of investigational compound elinzanetant in the treatment of moderate to severe vasomotor symptoms associated with menopause

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.